Exhibit 10.1


 


SECURITIES PURCHASE
AGREEMENT


 


THIS SECURITIES
PURCHASE AGREEMENT (the “Agreement”) is made as of the 7th day of October, 2015
by and between VIRTUS OIL AND GAS CORP., a Nevada corporation (the “Company”), and HIMMIL INVESTMENTS,
LTD., a British Virgin Island company (the “Investor”).


 


WHEREAS,
the Company and the Investor are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”), and Rule 506
of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission
(the “Commission”) under the 1933 Act (without limiting any other such exemption which may apply to the
transactions contemplated by this Agreement);


 


WHEREAS,
the Company has authorized the issuance of senior convertible notes, in the aggregate original principal amount of up to $600,000,
in the form attached hereto as Exhibit A (the “Notes”), which Notes shall be convertible into
shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), in accordance
with the terms of the Notes;


 


WHEREAS, Investor
wishes to purchase, and the Company wishes to sell at the Closing (as defined below), upon the terms and subject to the conditions
stated in this Agreement, a Note in the aggregate original principal amount as set forth in column (3) on Schedule I hereto
(the “Note” or “Notes”) (and the Common Stock issuable upon conversion thereof,
collectively, the “Conversion Shares”).


 


 


WHEREAS,
the Notes and the Conversion Shares are collectively referred to herein as the “Securities” and the offering
contemplated hereby is referred to herein as the “Offering”;


 


WHEREAS,
the parties have agreed that the obligation to repay the Notes shall be an unsecured obligation of the Company; and


 


WHEREAS,
at the Closing, the parties hereto shall execute and deliver a Registration Rights Agreement, in the form attached hereto as Exhibit
B (the “Registration Rights Agreement”), pursuant to which the Company has agreed to provide certain
registration rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement), under the 1933
Act and the rules and regulations promulgated thereunder, and applicable state securities laws.


 


NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and in consideration of the
premises and the mutual agreements, representations and warranties, provisions and covenants contained herein, the parties hereto,
intending to be legally bound hereby, agree as set forth below. Capitalized terms not otherwise defined herein shall have the meanings
set forth in Section 9 below.


 


1.             Purchase and Sale of Notes.


 


1.1             
Purchase and Sale of the Notes. Subject to the satisfaction (or, where legally permissible, the waiver) of the conditions
set forth in Section 5.1, the Company shall issue and sell to the Investor, and the Investor shall purchase from the Company on
the Closing Date, the Note in the aggregate original principal amount as set forth in column (3) on Schedule I hereto (the
“Closing”).


 



    	1



    	 



    




 


1.2             
Reserved.


 


1.3             
Form of Payment. On the Closing Date, (i) the Investor shall pay the Purchase Price (as defined below) (less the
amounts withheld pursuant to Section 4.6) to the Company for the Note to be issued and sold to the Investor at the Closing, by
wire transfer of immediately available funds in accordance with the Company’s written wire instructions and (ii) immediately
following the Company’s receipt of such amount, the Company shall deliver to the Investor a Note in the aggregate original
principal amount as set forth in column (3) on Schedule I hereto, duly executed on behalf of the Company and registered in the
name of the Investor or its designee.


 


1.4             
Purchase Price. The purchase price for the Note to be purchased by the Investor (the “Purchase Price”)
shall be the amount as set forth in column (5) on Schedule I hereto. As indicated on Schedule I, the Note will be
issued with an original issue discount of $25,000.


 


1.5             
Closing. The Closing shall occur at the offices of Kelly Drye, 101 Park Avenue, New York, NY 10178. The date and
time of the Closing (the “Closing Date”) shall be 10:00 a.m. (New York City time), on the first (1st)
Trading Day (as defined below) (and including the date hereof if a Trading Day) on which the conditions to the Closing set forth
in Section 5.1 below are satisfied or waived.


 


(a)               
Reserved.


 


(b)              
Reserved.


 


(c)               
Reserved.


 


2.             Representations and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure
Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure
contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and
warranties to the Investors as of the Closing Date (“Representation Date”):


 


2.1             
Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and
in good standing under the laws of the State of Nevada. The Company is duly qualified to transact business and is in good standing
in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.


 



    	2



    	 



    




 


2.2             
Capitalization and Voting Rights. The authorized capital stock of the Company and the shares thereof issued and outstanding
were as set forth in the Public Reports (as defined herein) as of the dates reflected therein. On or prior to each of the Closing
Date, the Company shall provide the Investor with a detailed capitalization table setting forth all of the Company’s outstanding
capital stock, and all options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities or rights convertible into or exchangeable for, any shares of capital stock of the Company (each, a “Current
Capitalization Table”). All of the outstanding shares of Common Stock have been duly authorized and validly issued,
and are fully paid and nonassessable. Except as set forth in the Current Capitalization Tables, the Public Reports, this Agreement
and the Registration Rights Agreement, there are no agreements or arrangements under which the Company is obligated to register
the sale of any securities under the 1933 Act. Except as set forth in the Current Capitalization Tables or the Public Reports,
no shares of Common Stock are entitled to preemptive rights and there are no outstanding debt securities and no contracts, commitments,
understandings, or arrangements by which the Company is or may become bound to issue additional shares of the capital stock of
the Company or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities or rights convertible into or exchangeable for, any shares of capital stock of the Company other than those issued
or granted in the ordinary course of business pursuant to the Company’s equity incentive and/or compensatory plans or arrangements.
Except for customary transfer restrictions contained in agreements entered into by the Company to sell restricted securities or
as set forth in the Public Reports or the Current Capitalization Tables, the Company is not a party to, and it has no knowledge
of, any agreement restricting the voting or transfer of any shares of the capital stock of the Company. Except as set forth in
the Public Reports or the Current Capitalization Tables, the offer and sale of all capital stock, convertible or exchangeable securities,
rights, warrants or options of the Company issued prior to the applicable Representation Date complied with all applicable federal
and state securities laws. Except as set forth in the Public Reports or the Current Capitalization Tables, there are no securities
or instruments containing anti-dilution or similar provisions that will be triggered by the Notes, this Agreement or the Registration
Rights Agreement or the consummation of the transactions described herein or therein.


 


2.3             
Authorization; Enforcement. All corporate action on the part of the Company, its officers, directors and stockholders
necessary for the authorization, execution and delivery of this Agreement, the Notes and the Registration Rights Agreement (the
“Transaction Documents”) and the performance of all obligations of the Company hereunder and thereunder,
and the authorization (or reservation for issuance), sale and issuance of the Notes, and the Common Stock into which the Notes
are convertible or exercisable have been taken on or prior to the date hereof. Each of the Transaction Documents has been duly
executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding
obligation of the Company enforceable against the Company in accordance with its terms, except: (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.


 



    	3



    	 



    




 


2.4             
Valid Issuance of the Conversion Shares; Reservation of Shares. The Notes have been duly authorized and, when issued
and paid for in accordance with this Agreement, will be duly and validly issued, fully paid and nonassessable, free and clear of
all Liens imposed by the Company other than restrictions on transfer under this Agreement and under applicable state and federal
securities laws. Upon conversion in accordance with the Notes, the Conversion Shares, when issued and delivered in accordance with
the terms of this Agreement and the Notes for the consideration expressed herein and therein, will be duly and validly issued,
fully paid and non-assessable, free and clear of all Liens imposed by the Company, other than restrictions on transfer under this
Agreement and under applicable state and federal securities laws. The Company has reserved from its duly authorized capital stock
a sufficient number of shares of Common Stock for issuance of the Conversion Shares as required by Section 8 of the Notes.


 


2.5             
Offering. Subject to the truth and accuracy of the Investor’s representations set forth in Section 3 of this
Agreement, the offer and issuance of the Securities as contemplated by this Agreement are exempt from the registration requirements
of the 1933 Act, and the qualification or registration requirements of state securities laws or other applicable blue sky laws.
Neither the Company nor any authorized agent acting on its behalf will take any action hereafter that would cause the loss of such
exemptions.


 


2.6             
Public Reports. The Company is current in its filing obligations under the 1934 Act, including without limitation
as to its filings of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K (collectively,
the “Public Reports”). Since January 1, 2013, the Company’s Public Reports do not contain any untrue
statement of a material fact or omit to state any fact necessary to make any statement therein not misleading. The financial statements
included within the Public Reports for the fiscal year ended November 30, 2014 and for each quarterly period thereafter (the “Financial
Statements”) have been prepared in accordance with generally accepted accounting principles (“GAAP”)
applied on a consistent basis throughout the periods indicated and with each other, except that unaudited Financial Statements
may not contain all footnotes required by generally accepted accounting principles. The Financial Statements fairly present, in
all material respects, the financial condition and operating results of the Company as of the dates, and for the periods, indicated
therein, subject in the case of unaudited Financial Statements to normal year-end audit adjustments. The Company has not been informed
by its independent accountants that they recommend that the Company amend or restate any of the Financial Statements or that there
is any need for the Company to amend or restate any of the Financial Statements.


 


2.7             
Compliance With Laws. The Company has not violated any law or any governmental regulation or requirement which violation
has had or would reasonably be expected to have a Material Adverse Effect on its business and the Company has not received written
notice of any such violation.


 


2.8             
Violations. The consummation of the transactions contemplated by the Transaction Documents and all other documents
and instruments required to be delivered in connection therewith will not result in or constitute any of the following: (a) a violation
of any provision of the certificate of incorporation, bylaws or other governing documents of the Company; (b) a violation of any
provisions of any applicable law or of any writ or decree of any court or governmental instrumentality; (c) a default or an event
that, with notice or lapse of time or both, would be a default, breach, or violation of a lease, license, promissory note, conditional
sales contract, commitment, indenture, mortgage, deed of trust, or other agreement, instrument, or arrangement to which the Company
is a party or by which the Company or its property is bound that would result in a Material Adverse Effect; (d) an event that would
permit any party to terminate any agreement or to accelerate the maturity of any Indebtedness or other obligation of the Company,
other than rights waived by Investor relating to the Investor May 2015 Financing (as defined herein); or (e) the creation or imposition
of any lien, pledge, option, security agreement, equity, claim, charge, encumbrance or other restriction or limitation upon outstanding
shares of capital stock or on any of the properties or assets of the Company.


 



    	4



    	 



    




 


2.9             
Consents; Waivers. No consent, waiver, approval or authority of any nature, or other formal action, by any Person,
firm or corporation, or any agency, bureau or department of any government or any subdivision thereof (other than the filing with
the Commission of one or more Registration Statements in accordance with the requirements of the Registration Rights Agreement,
a Form D with the Commission and any other filings as may be required by any state or foreign securities agencies), not already
obtained, is required in connection with the execution and delivery of the Transaction Documents by the Company or the consummation
by the Company of the transactions provided for herein and therein.


 


2.10         
Sarbanes-Oxley Act. The Company is in material compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission
thereunder that are effective as of the date hereof.


 


2.11         
Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public
board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against
or affecting the Company, the Common Stock or any of the Company’s officers or directors in their capacities as such. No
director, officer or employee of the Company or any of its subsidiaries has willfully violated 18 U.S.C. §1519 or engaged
in spoliation in reasonable anticipation of litigation. Without limitation of the foregoing, there has not been, and to the knowledge
of the Company, there is not pending or contemplated, any investigation by the SEC involving the Company, any of its Subsidiaries
or any current or former director or officer of the Company or any of its Subsidiaries in such role as an officer or director of
the Company or any of its Subsidiaries. The SEC has not issued any stop order or other order suspending the effectiveness of any
registration statement filed by the Company under the 1933 Act or the 1934 Act. After reasonable inquiry of its employees, the
Company is not aware of any fact which might result in or form the basis for any such action, suit, arbitration, investigation,
inquiry or other proceeding. Neither the Company nor any of its Subsidiaries is subject to any order, writ, judgment, injunction,
decree, determination or award of any court, agency or other governmental authority.


 


2.12         
Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial
statements included within the Public Reports, except as specifically disclosed in a subsequent Public Report filed prior to the
date hereof: (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result
in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade
payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not
required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution
of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of
its capital stock and (v) the Company has not issued any equity securities to any officer, director or affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its
Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would be required to be
disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been
publicly disclosed at least one Trading Day prior to the date that this representation is made.


 



    	5



    	 



    




 


2.13         
Intellectual Property. The Company has, or has rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights as described in the Public Reports as necessary or required for use in connection with their respective businesses
and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”).
None of, and the Company has not received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this
Agreement. The Company has not received, since the date of the latest audited financial statements included within the Public Reports,
a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights
of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of
the Intellectual Property Rights. The Company has taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.


 


2.14         
Registration Rights. Other than the Investor or as set forth in the Public Reports, no Person has any right to cause
the Company to effect the registration under the 1933 Act of any securities of the Company.


 


2.15         
Disclosure. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided the Investor or its agents
or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company
understands and confirms that the Investor will rely on the foregoing representation in effecting transactions in securities of
the Company. All of the disclosure furnished by or on behalf of the Company to the Investor regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is
true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do
not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.
The Company acknowledges and agrees that the Investor does not make nor has made any representations or warranties with respect
to the transactions contemplated hereby other than those specifically set forth in Section 3 hereof.


 



    	6



    	 



    




 


2.16         
No Integrated Offering. Assuming the accuracy of the Investor’s representations and warranties set forth in
Section 3 hereof, neither the Company, nor any of its affiliates, nor any Person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would
cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the 1933 Act which
would require the registration of any such securities under the 1933 Act, or (ii) any applicable shareholder approval provisions
of any Trading Market on which any of the securities of the Company are listed or designated.


 


2.17         
Seniority. As of the applicable Representation Date, no Indebtedness or other claim against the Company is senior
to the Notes in right of payment, whether with respect to interest or upon liquidation or dissolution, or otherwise, except for
Permitted Indebtedness.


 


2.18         
Bankruptcy Status; Indebtedness. The Company has no current intention or expectation to file for reorganization or
liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the applicable Representation
Date. The Public Reports set forth the outstanding secured and unsecured Indebtedness (as defined below) of the Company or any
Subsidiary, or for which the Company or any Subsidiary has commitments. The Company is not in default with respect to any Indebtedness.


 


2.19         
Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for
soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another
to purchase any other securities of the Company.


 


2.20         
Acknowledgment Regarding Investor’s Purchase of Securities. The Company acknowledges and agrees that the Investor
is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions
contemplated hereby and thereby and that the Investor is not (i) an officer or director of the Company or any of its Subsidiaries,
(ii) an “affiliate” (as defined in Rule 144) of the Company or any of its Subsidiaries or (iii) to its knowledge, a
“beneficial owner” of more than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the 1934
Act). The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company or any
of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby
and thereby, and any advice given by the Investor or any of its representatives or agents in connection with the Transaction Documents
and the transactions contemplated hereby and thereby is merely incidental to the Investor’s purchase of the Securities. The
Company further represents to the Investor that the Company’s decision to enter into the Transaction Documents to which it
is a party has been based solely on the independent evaluation by the Company and its representatives.


 



    	7



    	 



    




 


2.21         
No General Solicitation. Neither the Company, nor any of its Subsidiaries or affiliates, nor any Person acting on
its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D)
in connection with the offer or sale of the Securities.


 


2.22         
Dilutive Effect. The Company understands and acknowledges that the number of Conversion Shares will increase in certain
circumstances. The Company further acknowledges that its obligation to issue the Conversion Shares upon conversion of the Notes
in accordance with this Agreement and the Notes is absolute and unconditional, regardless of the dilutive effect that such issuance
may have on the ownership interests of other stockholders of the Company.


 


2.23         
Application of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary
action, if any, in order to render inapplicable any stockholder rights plan or similar arrangement (other than as provided by the
Nevada Revised Statutes) relating to accumulations of beneficial ownership of shares of Common Stock or a change in control of
the Company or any of its Subsidiaries.


 


2.24         
Foreign Corrupt Practices. Neither the Company nor any of its Subsidiaries nor any director, officer, agent, employee
or other Person (as defined herein) acting on behalf of the Company or any of its Subsidiaries has, in the course of its actions
for, or on behalf of, the Company or any of its Subsidiaries (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of
the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment,
kickback or other unlawful payment to any foreign or domestic government official or employee.


 


2.25         
Transactions With Affiliates. None of the officers, directors, employees or affiliates of the Company or any of its
Subsidiaries is presently a party to any transaction with the Company or any of its Subsidiaries (other than for ordinary course
services as employees, officers or directors), including any contract, agreement or other arrangement providing for the furnishing
of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from
any such officer, director, employee or affiliate or, to the knowledge of the Company or any of its Subsidiaries, any corporation,
partnership, trust or other Person in which any such officer, director, employee or affiliate has a substantial interest or is
an employee, officer, director, trustee or partner.


 


2.26         
Insurance. The Company and each of its Subsidiaries will use commercial efforts to obtain insurance against such
losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses in which
the Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has been refused any insurance coverage
sought or applied for, and neither the Company nor any such Subsidiary has any reason to believe that it will be unable to renew
its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be
necessary to continue its business at a cost that would not have a Material Adverse Effect.


 



    	8



    	 



    




 


2.27         
Employee Relations. Neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement
or employs any member of a union. The Company believes that its and its Subsidiaries’ relations with their respective employees
are good. No executive officer (as defined in Rule 501(f) promulgated under the 1933 Act) or other key employee of the Company
or any of its Subsidiaries has notified the Company or any such Subsidiary that such officer intends to leave the Company or any
such Subsidiary or otherwise terminate such officer’s employment with the Company or any such Subsidiary. No executive officer
or other key employee of the Company or any of its Subsidiaries is, or is now expected to be, in violation of any material term
of any employment contract, confidentiality, disclosure or proprietary information agreement, non-competition agreement, or any
other contract or agreement or any restrictive covenant, and the continued employment of each such executive officer or other key
employee (as the case may be) does not subject the Company or any of its Subsidiaries to any liability with respect to any of the
foregoing matters. The Company and its Subsidiaries are in compliance with all federal, state, local and foreign laws and regulations
respecting labor, employment and employment practices and benefits, terms and conditions of employment and wages and hours, except
where failure to be in compliance would not, either individually or in the aggregate, reasonably be expected to result in a Material
Adverse Effect.


 


2.28         
Reserved.


 


2.29         
Environmental Laws. The Company and its Subsidiaries (i) are in compliance with all Environmental Laws (as defined
below), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct
their respective businesses and (iii) are in compliance with all terms and conditions of any such permit, license or approval where,
in each of the foregoing clauses (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually
or in the aggregate, a Material Adverse Effect.


 


2.30         
Tax Status. The Company and each of its Subsidiaries (i) has timely made or filed all foreign, federal and state
income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has timely
paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations, except those being contested in good faith and (iii) has set aside on its books provision reasonably
adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply.
There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers
of the Company and its Subsidiaries know of no basis for any such claim. The Company is not operated in such a manner as to qualify
as a passive foreign investment company, as defined in Section 1297 of the Code.


 



    	9



    	 



    




 


2.31         
Internal Accounting and Disclosure Controls. As disclosed in its Public Reports, the Company does not maintain internal
controls over financial reporting (as such term is defined in Rule 13a-15(f) under the 1934 Act) that are effective to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles, including that (i) transactions are executed in accordance
with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of
financial statements in conformity with generally accepted accounting principles and to maintain asset and liability accountability,
(iii) access to assets or incurrence of liabilities is permitted only in accordance with management’s general or specific
authorization and (iv) the recorded accountability for assets and liabilities is compared with the existing assets and liabilities
at reasonable intervals and appropriate action is taken with respect to any difference. As disclosed in its Public Reports, the
Company does not maintain disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the 1934 Act) that
are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under
the 1934 Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Commission,
including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company
in the reports that it files or submits under the 1934 Act is accumulated and communicated to the Company’s management, including
its principal executive officer or officers and its principal financial officer or officers, as appropriate, to allow timely decisions
regarding required disclosure. Neither the Company nor any of its Subsidiaries has received any notice or correspondence from any
accountant or other Person relating to any potential material weakness or significant deficiency in any part of the internal controls
over financial reporting of the Company or any of its Subsidiaries, except as disclosed in Public Reports.


 


2.32         
Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or
any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company
in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.


 


2.33         
Investment Company Status. The Company is not, and upon consummation of the sale of the Securities will not be, an
“investment company,” an affiliate of an “investment company,” a company controlled by an “investment
company” or an “affiliated person” of, or “promoter” or “principal underwriter” for,
an “investment company” as such terms are defined in the Investment Company Act of 1940, as amended.


 


2.34         
U.S. Real Property Holding Corporation. Neither the Company nor any of its Subsidiaries is, or has ever been, and
so long as any of the Securities are held by the Investor, shall become, a U.S. real property holding corporation within the meaning
of Section 897 of the Code, and the Company and each Subsidiary shall so certify upon the Investor’s request.


 


2.35         
Bank Holding Company Act. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company
Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve
System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or affiliates owns or
controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five
percent (25%) or more of the total equity of a bank or any equity that is subject to the BHCA and to regulation by the Federal
Reserve. Neither the Company nor any of its Subsidiaries or affiliates exercises a controlling influence over the management or
policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.


 



    	10



    	 



    




 


2.36         
Shell Company Status. The Company is not currently a “shell company” (as defined in Rule 405 promulgated
under the 1933 Act) and filed current Form 10 information as an issuer identified in, or subject to, Rule 144(i), on August 20,
2014.


 


2.37         
Public Utility Holding Act. Neither the Company nor any of its Subsidiaries is a “holding company,” or
an “affiliate” of a “holding company,” as such terms are defined in the Public Utility Holding Act of 2005.


 


2.38         
Federal Power Act. Neither the Company nor any of its Subsidiaries is subject to regulation as a “public utility”
under the Federal Power Act, as amended.


 


2.39         
Illegal or Unauthorized Payments; Political Contributions. Neither the Company nor any of its Subsidiaries nor, to
the best of the Company’s knowledge (after reasonable inquiry of its officers and directors), any of the officers, directors,
employees, agents or other representatives of the Company or any of its Subsidiaries or any other business entity or enterprise
with which the Company or any Subsidiary is or has been affiliated or associated, has, directly or indirectly, made or authorized
any payment, contribution or gift of money, property, or services, whether or not in contravention of applicable law, (a) as a
kickback or bribe to any Person or (b) to any political organization, or the holder of or any aspirant to any elective or appointive
public office except for personal political contributions not involving the direct or indirect use of funds of the Company or any
of its Subsidiaries.


 


2.40         
Money Laundering. The Company and its Subsidiaries are in compliance with, and have not previously violated, the
USA Patriot Act of 2001 and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, without
limitation, the laws, regulations and Executive Orders and sanctions programs administered by the U.S. Office of Foreign Assets
Control, including, without limitation, (i) Executive Order 13224 of September 23, 2001 entitled, “Blocking Property and
Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism” (66 Fed. Reg. 49079 (2001));
and (ii) any regulations contained in 31 CFR, Subtitle B, Chapter V.


 


2.41         
No Disqualification Events. None of the Company, any of its predecessors, any affiliated issuer, any director, executive
officer, other officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more of
the Company's outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is
defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at the time of sale (each, an “Issuer
Covered Person”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i)
to (viii) under the 1933 Act (a “Disqualification Event”), except for a Disqualification Event covered
by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject
to a Disqualification Event.


 



    	11



    	 



    




 


2.42         
Non-Oil, Gas and Mineral Real Property. Each of the Company and its Subsidiaries holds valid use rights to all real
property, leases in real property, or other interests in real property owned or held by the Company or any of its Subsidiaries
(other than any property included in the Interests (as defined below)) (the “Other Real Property”) owned
by the Company or any of its Subsidiaries, as applicable. The Other Real Property is free and clear of all encumbrances and is
not subject to any rights of way, building use restrictions, exceptions, variances, reservations, or limitations of any nature
except for (a) liens for current taxes not yet due, (b) zoning laws and other land use restrictions that do not impair the present
or anticipated use of the property subject thereto or (c) those that do not have a Material Adverse Effect.


 


2.43         
Non-Oil, Gas and Mineral Fixtures and Equipment. Each of the Company and its Subsidiaries, as applicable, has good
title to, or a valid leasehold interest in, the material tangible personal property, equipment, improvements, fixtures, and other
personal property and appurtenances that are used by the Company or its Subsidiary in connection with the conduct of its business
(the “Company Fixtures and Equipment”), except that the Company Fixtures and Equipment do not include
any property included in the Interests. The Company Fixtures and Equipment are structurally sound, are in good operating condition
and repair, are adequate for the uses to which they are being put, are not in need of maintenance or repairs except for ordinary,
routine maintenance and repairs and are sufficient for the conduct of the Company's and/or its Subsidiaries’ businesses,
as applicable, in the manner as conducted prior to the Closing. Each of the Company and its Subsidiaries owns all of its Company
Fixtures and Equipment free and clear of all encumbrances except for (a) liens for current taxes not yet due, (b) zoning laws and
other land use restrictions that do not impair the present or anticipated use of the property subject thereto, or (c) those that
do not have a Material Adverse Effect.


 


2.44         
Oil, Gas and Mineral Interests. As of each Closing Date:


 


(a)         
For the purpose
of this Agreement, the following definitions shall apply:


 


		(i)	“Appurtenant Rights” means, with respect to the Properties (as defined
below), in each case, insofar as they may relate to the Properties, the Company’s or any of its Subsidiaries’, as applicable,
interest in (a) all presently existing and valid unitization and pooling declarations, agreements, and/or orders relating to or
affecting the Properties and all rights in the Properties covered by the Units (as defined below) created thereby; (b) all
wells, well and leasehold equipment, pipelines, platforms, facilities, improvements, goods and other personal property located
on or used in connection with the Properties; and (c) all presently existing production sales contracts, operating and other contracts
or agreements which relate to the Properties.



 


		(ii)	“Basic Documents” means all of the following documents and instruments,
including those that are recorded and unrecorded, with respect to the Company or any of its Subsidiaries:



 



    	12



    	 



    

 


(A)            
All material contracts and agreements comprising any part of, or relating or pertaining to, the Interests, including but
not limited to farm-in agreements, farm-out agreements, joint operating agreements, Unit agreements and contracts by which the
Interests were acquired;


 


(B)             
All agreements or arrangements for the sale, gathering, transportation, compression, treating, processing or other marketing
of a material volume of production from the Interests (including calls on, or other rights to purchase, production, whether or
not the same are currently being exercised), comprising any part of or otherwise relating or pertaining to the Interests; and


 


(C)             
All documents and instruments evidencing the Interests.


 


		(iii)	“Good and Defensible Title” means, as to the Interest in question, (i)
title to such Interest by virtue of which the Company or any of its Subsidiaries, as applicable, can successfully defend against
a claim to the contrary made by a third party, based upon industry standards in the acquisition of oil and gas properties, and
in the exercise of reasonable judgment and in good faith; and, (ii) in the case of the Wells (as defined below), title that entitles
the Company or such Subsidiary, as applicable, to receive not less than the Net Revenue Interest (as defined below) for each of
the Wells, and obligates the Company or such Subsidiary, as applicable, to bear not more than the Working Interest for each of
the Wells (unless there is a corresponding increase in the Net Revenue Interest for a respective Well); and (iii) such Interest
is subject to no liens, encumbrances, obligations or defects that would have a Material Adverse Effect other than as set forth
in the Basic Documents.



		(iv)	“Interests” means the Properties and the Appurtenant Rights of
the Company and its Subsidiaries.



		(v)	“Net Revenue Interest” means a share, expressed as a decimal, of the
oil, gas and other minerals (or the proceeds of sale thereof) produced and saved from or otherwise attributable to an Interest
and the zones, horizons and reservoirs produced therefrom, after the deduction of all royalties, overriding royalties and other
burdens on production.



		(vi)	“Properties” means all of the Company's and its Subsidiaries’ rights,
titles and interests in and to the following oil and gas and/or mineral properties:



(A)            
All oil, gas and/or mineral leases and other mineral interests, including, but not limited to, all of the Company's operating
rights, record title interests, working interests, and overriding royalty interests, without depth or other restrictions or exclusions;


 



    	13



    	 



    




 


(B)             
All Wells of the Company and its Subsidiaries;


 


(C)             
All surface leases, rights-of-way, easements, servitudes and other rights-of-use (whether surface, subsurface or subsea);
and


 


(D)            
All licenses and servitudes.


 


		(vii)	“Units” means oil, gas and other mineral production, proration, or other
types of units, and any ownership interests therein.



		(viii)	“Well” or “Wells” means all of the Company's
and any of its Subsidiaries' oil, gas and condensate wells, (whether producing, not producing or abandoned or temporarily abandoned).



		(ix)	“Working Interest” means a share, expressed as a decimal, of the costs
of exploring, drilling, developing and operating an Interest and producing oil, gas and other minerals from the zones, horizons
and reservoirs therein and thereunder.



 


(b)         
The Company
holds Good and Defensible Title to the Interests in accordance with the Basic Documents.


 


(c)         
The Basic Documents
are in full force and effect and constitute valid and binding obligations of the parties thereto.


 


(d)         
Neither the
Company nor any of its Subsidiaries is in material breach or default (and no situation exists which with the passing of time or
giving of notice would give rise to such a breach or default) of its obligations under any Basic Document and no breach or default
by any other party to any Basic Document (or situation which with the passage of time or giving of notice would give rise to such
a breach or default) exists, to the extent such breach or default (whether by the Company, any Subsidiary or another party to any
Basic Document) could have a Material Adverse Effect on any of the Interests.


 


2.45         
Stock Option Plans. Each stock option granted by the Company was granted (i) in accordance with the terms of the
applicable stock option plan of the Company and (ii) with an exercise price at least equal to the fair market value of the Common
Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company's stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no policy or
practice of the Company to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options
with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial
results or prospects.


 



    	14



    	 



    




 


2.46         
No Disagreements with Accountants and Lawyers. There are no material disagreements of any kind presently existing,
or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed
by the Company and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company's
ability to perform any of its obligations under any of the Transaction Documents. In addition, on or prior to the date hereof,
the Company had discussions with its accountants about its financial statements previously filed with the SEC. Based on those discussions,
the Company has no reason to believe that it will need to restate any such financial statements or any part thereof.


 


2.47         
No Disqualification Events. With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b)
under the 1933 Act (“Regulation D Securities”), none of the Company, any of its predecessors, any affiliated
issuer, any director, executive officer, other officer of the Company participating in the offering contemplated hereby, any beneficial
owner of 20% or more of the Company's outstanding voting equity securities, calculated on the basis of voting power, nor any promoter
(as that term is defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at the time of sale (each,
an “Issuer Covered Person” and, together, “Issuer Covered Persons”) is subject to
any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the 1933 Act (a “Disqualification
Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable
care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent
applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Investor a copy of any disclosures provided
thereunder.


 


2.48         
Other Covered Persons. The Company is not aware of any Person that has been or will be paid (directly or indirectly)
remuneration for solicitation of the Investor or potential purchasers in connection with the sale of any Regulation D Securities.


 


3.             Representations and Warranties of the Investor. The Investor hereby represents, warrants and covenants that:


 


3.1         
Authorization. The Investor has full power and authority to enter into this Agreement, to perform its obligations
hereunder and to consummate the transactions contemplated hereby and has taken all action necessary to authorize the execution
and delivery of this Agreement and the Registration Rights Agreement, the performance of its obligations hereunder and thereunder
and the consummation of the transactions contemplated hereby and thereby.


 


3.2         
No Public Sale or Distribution. The Investor is (i) acquiring the Notes and (ii) upon conversion of the Notes will
acquire the Conversion Shares for its own account, not as a nominee or agent, and not with a view towards, or for resale in connection
with, the public sale or distribution of any part thereof, except pursuant to sales registered or exempted under the 1933 Act.
The Investor is acquiring the Securities hereunder in the ordinary course of its business. The Investor does not presently have
any contract, agreement, undertaking, arrangement or understanding, directly or indirectly, with any Person to sell, transfer,
pledge, assign or otherwise distribute any of the Securities.


 



    	15



    	 



    




 


3.3             
Accredited Investor Status; Investment Experience. The Investor is an “accredited investor” as that term
is defined in Rule 501(a) of Regulation D. The Investor can bear the economic risk of its investment in the Securities, and has
such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of an investment
in the Securities.


 


3.4             
Reliance on Exemptions. The Investor understands that the Securities are being offered and sold to it in reliance
on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company
is relying in part upon the truth and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Investor set forth herein in order to determine the availability of such exemptions and
the eligibility of the Investor to acquire the Securities.


 


3.5             
Information. The Investor and its advisors, if any, have been furnished with all materials relating to the business,
finances and operations of the Company and materials relating to the offer and sale of the Securities which have been requested
by the Investor. The Investor and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither
such inquiries nor any other due diligence investigations conducted by the Investor or its advisors, if any, or its representatives
shall modify, amend or affect the Investor’s right to rely on the Company’s representations and warranties contained
herein. The Investor understands that its investment in the Securities involves a high degree of risk. The Investor has sought
such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its
acquisition of the Securities. The Investor is relying solely on its own accounting, legal and tax advisors, and not on any statements
of the Company or any of its agents or representatives, for such accounting, legal and tax advice with respect to its acquisition
of the Securities and the transactions contemplated by this Agreement.


 


3.6             
No Governmental Review. The Investor understands that no United States federal or state agency or any other government
or governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability
of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.


 


3.7             
Validity; Enforcement; No Conflicts. This Agreement and each Transaction Document to which the Investor is a party
have been duly and validly authorized, executed and delivered on behalf of the Investor and shall constitute the legal, valid and
binding obligations of the Investor enforceable against the Investor in accordance with their respective terms, except as such
enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and
remedies. The execution, delivery and performance by the Investor of this Agreement and each Transaction Document to which the
Investor is a party and the consummation by the Investor of the transactions contemplated hereby and thereby will not (i) result
in a violation of the organizational documents of the Investor or (ii) conflict with, or constitute a default (or an event which
with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture or instrument to which the Investor is a party, or (iii) result in a violation of
any law, rule, regulation, order, judgment or decree (including federal and state securities or “Blue Sky” laws) applicable
to the Investor, except in the case of clause (ii) above, for such conflicts, defaults or rights which would not, individually
or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Investor to perform its obligations
hereunder.


 



    	16



    	 



    




 


3.8             
General Solicitation. Such Investor is not purchasing the Securities as a result of any advertisement, article, notice
or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television
or radio or presented at any seminar.


 


3.9             
Certain Trading Activities. Such Investor has not directly or indirectly, nor has any Person acting on behalf of
or pursuant to any understanding with such Investor, engaged in any transactions in the securities of the Company (including, without
limitation, any short sales involving the Company’s securities) between the time that such Investor was first contacted by
the Company regarding an investment in the Company and the date of this Agreement. Such Investor covenants that neither it, nor
any person acting on its behalf or pursuant to any understanding with it, will engage in any transactions in the securities of
the Company (including short sales) (a) prior to the time that the transactions contemplated by this Agreement are publicly disclosed,
or (b) in violation of any laws or any rules or regulations of the Commission.


 


3.10         
Compliance with Laws. If the Investor is not a United States person (as defined by Section 7701(a)(30) of the Code),
such Investor hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection
with any invitation to subscribe for the Securities or any use of this Agreement, including (i) the legal requirements within its
jurisdiction for the purchase of the Securities, (ii) any foreign exchange restrictions applicable to such purchase, (iii) any
governmental or other consents that may need to be obtained, and (iv) the income tax and other tax consequences, if any, that may
be relevant to the purchase, holding, redemption, sale, or transfer of the Securities. Such Investor’s subscription and payment
for and continued beneficial ownership of the Securities will not violate any applicable securities or other laws of the Investor’s
jurisdiction.


 


3.11         
Consent and Waiver. The Investor entered into a securities purchase agreement dated May 22, 2015 (“SPA”)
pursuant to which a convertible note was issued, as well as a registration rights agreement dated May 22, 2015 (“RRA”),
and pursuant to the SPA, two additional notes were issued on June 22, 2015 and August 11, 2015, respectively, which, combined with
the May 2015 note, aggregated a principal amount of $800,000 (the “Three Notes” and collectively with
the SPA and RRA, the “Investor May 2015 Financing”). By entering into this Agreement, the Investor hereby
consents to the entry into the Transaction Documents and waives any breach or violation of the Investor May 2015 Financing documents
as a result of entering into the Transaction Documents and, specifically, acknowledge its (i) consent to the entry into this Agreement
as required pursuant to section 4.13 of the SPA, (ii) agreement that the issuance of the Note and entry into the Transaction Documents
will not be deemed a Dilutive Issuance (as defined in the Three Notes) pursuant to Section 6 of the Three Notes and there will
be no adjustment of the fixed conversion price in the Three Notes as a result of the issuance of this Note, and (iii) consent to
the issuance of the Note and entry into the Transaction Documents for purposes of waiving compliance with any covenant set forth
in Section 13 of the Three Notes.


 



    	17



    	 



    




 


4.             Covenants.


 


4.1             
Best Efforts. The Investor shall use its best efforts to timely satisfy each of the conditions to be satisfied by
it as provided in Section 5.1(a) of this Agreement. The Company shall use its best efforts to timely satisfy each of the conditions
to be satisfied by it as provided in Section 5.1(b) of this Agreement.


 


4.2             
Use of Proceeds; Revenues. The Company will use the proceeds received from the purchase of the Securities for, among
other things, (i) costs and expenses relating to the sale of the Securities to the Investor, and (ii) general working capital purposes.


 


4.3             
Form D and Blue Sky. The Company shall file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof to the Investor promptly after such filing. The Company shall, on or before the Closing Date, if
such Investor is a U.S. person (as defined by Section 7701(a)(30) of the Code), take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to, qualify the Securities for sale to the Investor pursuant to
this Agreement under applicable securities or “Blue Sky” laws of the states of the United States (or to obtain an exemption
from such qualification), and shall provide evidence of any such action so taken to the Investor on or prior to the Closing Date.
Without limiting any other obligation of the Company under this Agreement, the Company shall timely make all filings and reports
relating to the offer and sale of the Securities required under all applicable securities laws (including, without limitation,
all applicable federal securities laws and all applicable “Blue Sky” laws), and the Company shall comply with all applicable
federal, foreign, state and local laws, statutes, rules, regulations and the like relating to the offering and sale of the Securities
to the Investor.


 


4.4             
Securities Law Disclosure; Publicity. The Company shall (a) by 9:00 a.m. (New York City time) on the Trading Day
immediately following the Closing Date, issue a press release in form and substance reasonably acceptable to the Investor disclosing
the material terms of the transactions contemplated hereby (the “Press Release”) and (b) issue a Current
Report on Form 8-K (the “Current Report”) disclosing the material terms of the transactions contemplated
hereby, and including the Transaction Documents as exhibits thereto, within the time required by the 1934 Act. From and after the
issuance of the Press Release, the Company represents to the Investor that the Company shall have publicly disclosed all material,
non-public information delivered to the Investor as of such time by the Company or any of its Subsidiaries, or any of their respective
officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers,
directors, affiliates, employees or agents, on the one hand, and the Investor or any of its affiliates, on the other hand, shall
terminate. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective officers,
directors, employees and agents not to, provide the Investor with any material, non-public information regarding the Company or
any of its Subsidiaries from and after the date hereof without the express prior written consent of the Investor (which may be
granted or withheld in the Investor’s sole discretion). To the extent that the Company delivers any material, non-public
information to the Investor without the Investor’s consent, the Company hereby covenants and agrees that the Investor shall
not have any duty of confidentiality with respect to, or a duty not to trade on the basis of, such material, non-public information.
The Company shall afford the Investor and its counsel with a reasonable opportunity to review and comment upon, shall consult with
the Investor and its counsel on the form and substance of, and shall give due consideration to all such comments from the Investor
or its counsel on, any press release, Commission filing or any other public disclosure made by or on behalf of the Company relating
to the Investor, its purchases hereunder or any aspect of the Transaction Documents or the transactions contemplated thereby, prior
to the issuance, filing or public disclosure thereof, and the Company shall not issue, file or publicly disclose any such information
to which the Investor shall object. For the avoidance of doubt, the Company shall not be required to submit for review any such
disclosure contained in periodic reports filed with the Commission under the 1934 Act if it shall have previously provided the
same disclosure for review in connection with a previous filing.


 



    	18



    	 



    




 


4.5             
Legends. The Securities may only be disposed of in compliance with state and federal securities laws. The Investor
acknowledges that the Company was previously a shell company (as defined in Rule 405 of Regulation C). In connection with any transfer
of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an affiliate of the
Investor or in connection with a pledge, the Company may require the transferor thereof to provide to the Company an opinion of
counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under
the 1933 Act. The Investor understands that the certificate or other instrument representing the Notes and the stock certificates
representing the Conversion Shares, except as set forth below, shall bear any legends as required by applicable state securities
or “Blue Sky” laws in addition to a restrictive legend in substantially the following form (and a stop-transfer order
may be placed against transfer of such stock certificates):


 


[NEITHER THE
ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE
HAVE BEEN] [THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE
OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF
COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED
UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE
FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED
BY THE SECURITIES.


 


The Company shall
use its best efforts (including, without limitation, delivering at the Company’s expense unless required to be delivered
by the Investor, all such legal opinions, consents, certificates, resolutions and instructions to the Company’s transfer
agent, and any successor transfer agent of the Company, as may be requested from time to time by the Investor or necessary or desirable
to carry out the intent and accomplish the purposes of this paragraph) to cause its transfer agent to remove the legend set forth
above and to issue a certificate without such legend to the holder of the Securities upon which it is stamped, or to issue to such
holder by electronic delivery at the applicable balance account at DTC, unless otherwise required by state securities or “blue
sky” laws, at such time (i) following a sale of such Securities under the 1933 Act provided the receipt by the Company or
the transfer agent of the deliverables by the Investor as set forth in the letter of instruction to the transfer agent in the form
attached as Exhibit C, (ii) in connection with a sale, assignment or other transfer (other than under Rule 144 or Rule 144A),
such holder provides the Company with an opinion of counsel, in a form generally acceptable to the Company’s legal counsel
and the Company’s transfer agent, to the effect that such sale, assignment or transfer of the Securities may be made without
registration under the 1933 Act, or (iii) following or in contemplated of a sale of such Securities under Rule 144 or Rule 144A,
such holder provides the Company and its legal counsel with reasonable assurance in writing in the form of acknowledgment attached
as Annex B to Exhibit D that the Securities are being sold, assigned or transferred pursuant to Rule 144 (which shall not
include an opinion of Investor’s counsel). In furtherance of the foregoing, the Company agrees that, following the time such
legend is not required pursuant to this Section 4.5, the Company shall, no later than three Trading Days following the delivery
by the Investor to the Company or the Company’s transfer agent of (i) a certificate representing Conversion Shares issued
with a restrictive legend and (ii) the deliverables contemplated in Exhibit C or Exhibit D, as is applicable (such
third Trading Day, the “Legend Removal Date”), either: (A) issue and deliver (or cause to be issued and
delivered) to the Investor a certificate representing such Conversion Shares that is free from all restrictive and other legends
or (B) cause the Company’s transfer agent to credit the Investor’s or its designee’s account at DTC through its
Deposit/Withdrawal at Custodian (DWAC) system with a number of shares of Common Stock equal to the number of Conversion Shares
represented by the certificate so delivered by the Investor. If the Company fails on or prior to the Legend Removal Date to either
(i) issue and deliver (or cause to be issued and delivered) to the Investor a certificate representing the Conversion Shares that
is free from all restrictive and other legends or (ii) cause the Company’s transfer agent to credit the balance account of
the Investor or its designee at DTC through its Deposit/Withdrawal at Custodian (DWAC) system with a number of shares of Common
Stock equal to the number of the Conversion Shares represented by the certificate delivered by the Investor pursuant hereto, then,
in addition to all other remedies available to the Investor, the Company shall pay in cash to the Investor on each day after the
Legend Removal Date that the issuance or credit of such shares is not timely effected an amount equal to 2.0% of the product of
(A) the sum of the number of Conversion Shares not issued to the Investor on a timely basis and to which the Investor is entitled
multiplied by (B) the Closing Sale Price (as defined in the Notes) of the Common Stock on the Trading Day immediately preceding
the Legend Removal Date. In addition to the foregoing, if the Company fails to so properly deliver such unlegended certificates
or so properly credit the account of the Investor or its designee at DTC by the Legend Removal Date, and if on or after the Legend
Removal Date the Investor purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction
of a sale by the Investor of shares of Common Stock that the Investor anticipated receiving from the Company without any restrictive
legend, then the Company shall, within three Trading Days after the Investor’s request, pay cash to the Investor in an amount
equal to the Investor’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so
purchased, at which point the Company’s obligation to deliver a certificate or credit the Investor’s or its designee’s
account at DTC for such shares of Common Stock shall terminate and such shares shall be cancelled.


 



    	19



    	 



    




 


4.6             
Fees and Expenses. Each party shall bear its own fees and expenses related to the transactions contemplated by the
Transaction Documents; provided, however, that $25,000 shall be withheld by the Investor from the Purchase Price, as a non-accountable
and non-refundable document preparation fee (the “Document Preparation Fee”) in connection with the preparation,
negotiation, execution and delivery of the Transaction Documents, legal due diligence of the Company, and review of the Registration
Statement(s) on behalf of the Investor. For the avoidance of doubt, the Document Preparation Fee shall be non-refundable when paid.
The Company shall pay all transfer agent fees (including, without limitation, any fees required for same-day processing of any
instruction letter delivered by the Company and any conversion or exercise notice delivered by an Investor), stamp taxes and other
taxes and duties levied in connection with the delivery of any Securities to the Investor. Each party represents that it will be
obligated for any finders’ fee or commission incurred by it in connection with this transaction and each of the Investor
and Company shall indemnify and hold harmless the other from any liability for any commission or compensation in the nature of
a finders’ fee (and the costs and expenses of defending against such liability or asserted liability).


 


4.7             
No Net Short Sales. So long as the Notes remain outstanding, neither the Investor nor any of its affiliates nor any
entity managed or controlled by the Investor (collectively, the “Restricted Persons” and each of the
foregoing is referred to herein as a “Restricted Person”) shall maintain, in the aggregate, a Net Short
Position.  For purposes hereof, a “Net Short Position” by a Restricted Person means a position whereby
such Restricted Person has executed one or more sales of Common Stock that is marked as a short sale (but not including any sale
marked “short exempt”) and that is executed at a time when such Restricted Person does not have an equivalent
offsetting long position in the Common Stock (or is deemed to have a long position hereunder or otherwise in accordance with Regulation
SHO under the 1934 Act); provided, further that no “Short Sale” shall be deemed to exist as a result of any failure
by the Company (or its agents) to deliver Conversion Shares upon conversion of the Notes to any Restricted Person converting such
Notes. For purposes of determining whether a Restricted Person has an equivalent offsetting long position in the Common Stock,
such Restricted Person shall be deemed to hold “long” all Common Stock that is either (i) then owned by such Restricted
Person, if any, or (ii) then issuable to such Restricted Person as Conversion Shares pursuant to the terms of the Notes then held
by such Restricted Person, if any, (without regard to any limitations on conversion set forth in the Notes and giving effect to
any conversion price adjustments that would take effect given only the passage of time). Notwithstanding the foregoing, nothing
contained herein shall (without implication that the contrary would otherwise be true) prohibit any Restricted Person from
selling “long” (as defined under Rule 200 promulgated under Regulation SHO under the 1934 Act) the Securities or any
other Common Stock then owned by such Restricted Person.


 



    	20



    	 



    




 


4.8             
Notice of Disqualification Events. The Company will notify the Investor in writing, prior to the Closing Date of
(i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time,
become a Disqualification Event relating to any Issuer Covered Person.


 


4.9             
Regulation M; General Solicitation. The Company will not take any action prohibited by Regulation M under the 1934
Act, in connection with the distribution of the Securities contemplated hereby. None of the Company, any of its affiliates (as
defined in Rule 501(b) under the 1933 Act) or any person acting on behalf of the Company or such affiliate will solicit any offer
to buy or offer or sell the Securities by means of any form of general solicitation or general advertising within the meaning of
Regulation D, including: (i) any advertisement, article, notice or other communication published in any newspaper, magazine
or similar medium or broadcast over television or radio; and (ii) any seminar or meeting whose attendees have been invited by any
general solicitation or general advertising.


 


4.10         
Pledge of Securities. Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges
and agrees that the Securities may be pledged by the Investor in connection with a bona fide margin agreement or other loan or
financing arrangement that is secured by the Securities. The pledge of Securities shall not be deemed to be a transfer, sale or
assignment of the Securities hereunder, and the Investor shall not be required to provide the Company with any notice thereof or
otherwise make any delivery to the Company pursuant to this Agreement or any other Transaction Document. The Company hereby agrees
to execute and deliver such documentation as a pledgee of the Securities may reasonably request in connection with a pledge of
the Securities to such pledgee by the Investor.


 


4.11         
No Integration. None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act), or any
person acting on behalf of the Company or such affiliate will sell, offer for sale, or solicit offers to buy or otherwise negotiate
in respect of any security (as defined in the 1933 Act) which will be integrated with the sale of the Securities in a manner which
would require the registration of the Securities under the 1933 Act or require stockholder approval under the rules and regulations
of the Trading Market and the Company will take all action that is appropriate or necessary to assure that its offerings of other
securities will not be integrated for purposes of the 1933 Act or the rules and regulations of the Trading Market, with the issuance
of Securities contemplated hereby.


 


4.12         
Passive Foreign Investment Company. The Company shall conduct its business, and shall cause its Subsidiaries to conduct
their respective businesses, in such a manner as will ensure that the Company will not be deemed to constitute a passive foreign
investment company within the meaning of Section 1297 of the Code.


 



    	21



    	 



    




 


4.13         
Limitations on Transactions; No Frustration. So long as the Investor or its affiliates hold any Securities, neither
the Company nor any of its affiliates or Subsidiaries, nor any of its or their respective officers, employees, directors, agents
or other representatives, will, without the prior written consent of the Investor (which consent may be withheld, delayed or conditioned
in the Investor’s sole discretion), effect, enter into, announce or recommend to its stockholders any agreement, plan, arrangement
or transaction (or issue, amend or waive any security) that would or would reasonably be expected to (i) constitute or involve
a Variable Rate Transaction or (ii) restrict, delay, conflict with or impair the ability or right of the Company to timely perform
its obligations under this Agreement or the Notes, including, without limitation, the obligation of the Company to timely deliver
shares of Common Stock to the Investor or its affiliates in accordance with this Agreement or the Notes. So long as the Investor
or its affiliates hold any Notes, the Company and/or its affiliates shall not directly or indirectly, solicit, initiate or enter
into any agreement to effect an “Exchange Transaction” (as such term is defined in Section 3(a)(9) or Section 3(a)(10)
of the 1933 Act.


 


4.14         
Volume Restriction. So long as the Investor or its affiliates hold any Securities, the Investor shall not sell Conversion
Shares in an amount exceeding the greater of (i) $125,000 worth of Common Stock, in the aggregate, in any five (5) Trading Day
period and (ii) on any single Trading Day, 15% of the composite aggregate dollar trading volume of the Common Stock as reported
on Bloomberg, L.P. for such Trading Day; provided, however, that if on any single Trading Day, the composite aggregate
dollar trading volume of the Common Stock as reported on Bloomberg, L.P. for such Trading Day is greater than $150,000, the Investor
may sell Conversion Shares up to an amount not exceeding 50% of the composite aggregate dollar trading volume of the Common Stock
as reported on Bloomberg, L.P. for such Trading Day. If the average Closing Sale Price (as defined in the Note) for any five (5)
Trading Day period is below $0.20 (as adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or
other similar transactions after the date hereof) on any Trading Day, all of the volume restrictions set forth in this Section
4.13 shall cease to apply for so long as the Investor or its affiliates hold any Securities.


 


4.15         
Closing Documents. On or prior to fourteen (14) calendar days after the Closing Date, the Company agrees to deliver,
or cause to be delivered, to the Investor and Kelley Drye & Warren LLP & Warren LLP a complete closing set of the executed
Transaction Documents, Securities and any other document required to be delivered to any party pursuant to Section 5 hereof
or otherwise.


 


5.             Closing Conditions.


 


5.1             
Conditions to the Closing.


 


(a)               
Conditions of the Company to the Closing. The obligation of the Company to sell and issue the Note to the Investor
at the Closing is subject to the fulfillment, to the Company’s reasonable satisfaction, prior to or at the Closing, of each
of the following conditions:


 



    	22



    	 



    




 


(i)                
Representations and Warranties. The representations and warranties of the Investor contained in this Agreement (x)
that are not qualified by “materiality” shall have been true and correct in all material respects when made and shall
be true and correct in all material respects as of the Closing Date with the same force and effect as if made on such dates, except
to the extent such representations and warranties are as of another date, in which case, such representations and warranties shall
be true and correct in all material respects as of such other date and (y) that are qualified by “materiality”
shall have been true and correct when made and shall be true and correct as of the Closing Date with the same force and effect
as if made on such dates, except to the extent such representations and warranties are as of another date, in which case, such
representations and warranties shall be true and correct as of such other date.


 


(ii)              
Registration Rights Agreement. The Investor shall have duly executed and delivered the Registration Rights Agreement
to the Company.


 


(iii)              No Injunction. No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered,
promulgated, threatened or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of or which would materially modify or delay any of the transactions contemplated by the Transaction Documents.


 


(b)              
Conditions to the Investor to the Closing. The obligation of the Investor to purchase the Note to be issued to the
Investor at the Closing is subject to the satisfaction, or (where legally permissible) the waiver by the Investor, on the Closing
Date, of each of the following conditions:


 


(i)                
Representations and Warranties. The representations and warranties of the Company contained in this Agreement (x)
that are not qualified by “materiality” or “Material Adverse Effect” shall have been true and correct in
all material respects when made and shall be true and correct in all material respects as of the Closing Date with the same force
and effect as if made on such dates, except to the extent such representations and warranties are as of another date, in which
case, such representations and warranties shall be true and correct in all material respects as of such other date and (y) that
are qualified by “materiality” or “Material Adverse Effect” shall have been true and correct when made
and shall be true and correct as of the Closing Date with the same force and effect as if made on such dates, except to the extent
such representations and warranties are as of another date, in which case, such representations and warranties shall be true and
correct as of such other date.


 


(ii)              
Performance of the Company. The Company shall have performed, satisfied and complied in all material respects with
all covenants, agreements and conditions required by this Agreement and the Registration Rights Agreement to be performed, satisfied
or complied with by the Company at or prior to the Closing Date. The Company shall have delivered to the Investor on the Closing
Date a written certification by an executive officer of the Company to the foregoing substantially in the form attached hereto
as Exhibit E.


 



    	23



    	 



    




 


(iii)            
No Suspension of Trading in or Notice of Delisting of Common Stock. Trading in the Common Stock shall not have been
suspended by the Commission, the Trading Market or the FINRA (except for any suspension of trading of less than fourteen (14) days,
which suspension shall be terminated prior to the Closing Notice Date), the Company shall not have received any final and non-appealable
notice that the listing or quotation of the Common Stock on the Trading Market shall be terminated on a date certain (unless, prior
to such date certain, the Common Stock is listed or quoted on any other Trading Market), trading in securities generally as reported
on the Trading Market shall not have been suspended or limited, nor shall a banking moratorium have been declared either by the
U.S. or New York State authorities (except for any suspension, limitation or moratorium which shall be terminated prior to the
Closing Notice Date), there shall not have been imposed any suspension of electronic trading or settlement services by the Depository
Trust Company (“DTC”) with respect to the Common Stock that is continuing, the Company shall not have
received any notice from DTC to the effect that a suspension of electronic trading or settlement services by DTC with respect to
the Common Stock is being imposed or is contemplated (unless, prior to such suspension, DTC shall have notified the Company in
writing that DTC has determined not to impose any such suspension), nor shall there have occurred any material outbreak or escalation
of hostilities or other national or international calamity or crisis that has had or would reasonably be expected to have a material
adverse change in any U.S. financial, credit or securities market that is continuing.


 


(iv)            
Compliance with Laws. The Company shall have complied with all applicable federal, state and local governmental laws,
rules, regulations and ordinances in connection with the execution, delivery and performance of this Agreement and the other Transaction
Documents (as defined below) to which it is a party and the consummation of the transactions contemplated hereby and thereby, including,
without limitation, the Company shall have obtained all permits and qualifications required by any applicable state securities
or “Blue Sky” laws for the offer and sale of the Securities by the Company to the Investor and the subsequent resale
of the Registrable Securities by the Investor (or shall have the availability of exemptions therefrom).


 


(v)              
No Injunction. No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered,
promulgated, threatened or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of or which would materially modify or delay any of the transactions contemplated by the Transaction Documents.


 


(vi)            
No Proceedings or Litigation. No action, suit or proceeding before any arbitrator or any court or governmental authority
shall have been commenced or threatened, and no inquiry or investigation by any governmental authority shall have been commenced
or threatened, against the Company or any Subsidiary, or any of the officers, directors or affiliates of the Company or any Subsidiary,
seeking to restrain, prevent or change the transactions contemplated by the Transaction Documents, or seeking material damages
in connection with such transactions.


 


(vii)          
Listing of Securities. All of the Conversion Shares that may be issued pursuant to the Notes shall have been approved
for listing or quotation on the Trading Market as of the Closing Date, in each case and as is applicable, without regard to any
limitations on conversion or exercise set forth in the Notes, subject only to notice of issuance.


 



    	24



    	 



    




 


(viii)        
No Material Adverse Effect. No condition, occurrence, state of facts or event constituting a Material Adverse Effect
shall have occurred and be continuing.


 


(ix)           
Opinion of Counsel. On the Closing Date, the Investor shall have received an opinion from outside counsel to the
Company, dated the Closing Date, in the form mutually agreed to by the parties hereto prior to the date hereof.


 


(x)             
Note. At the Closing, the Company shall have tendered to the Investor the Note.


 


(xi)            
Registration Rights Agreement. The Company shall have duly executed and delivered the Registration Rights Agreement
to the Investor.


 


(xii)          
Current Public Information. All reports, schedules, registrations, forms, statements, information and other documents
required to have been filed by the Company with the Commission pursuant to the reporting requirements of the 1934 Act, including
all material required to have been filed pursuant to Section 13(a) or 15(d) of the 1934 Act, shall have been filed with the Commission
under the 1934 Act.


 


5.2             
Reserved.


 


5.3             
Reserved.


 


6.             Termination. In the event that the Closing shall not have occurred within ten (10) days after the date hereof, each
of the Company and the Investor shall have the right to terminate its respective obligations under this Agreement at any time on
or after the close of business on such date without liability to any other party; provided, however, the right to terminate its
obligations under this Agreement pursuant to this Section 6 shall not be available to such terminating party if the failure of
the transactions contemplated by this Agreement to have been consummated by such date is the result of such party’s breach
of this Agreement; and provided, further that no such termination shall affect any obligation of the Company under this Agreement
to reimburse the Investor for the expenses described in Section 4.6 above. Nothing contained in this Section 6 shall be deemed
to release any party from any liability for any breach by such party of the terms and provisions of this Agreement or the other
Transaction Documents or to impair the right of any party to compel specific performance by any other party of its obligations
under this Agreement or the other Transaction Documents.


 



    	25



    	 



    




 


7.             Indemnification. In consideration of the Investor’s execution and delivery of the Transaction Documents and
acquiring the Securities thereunder and in addition to all of the Company’s other obligations under the Transaction Documents,
the Company shall defend, protect, indemnify and hold harmless the Investor and each holder of any Securities and all of their
stockholders, partners, members, officers, directors, employees and direct or indirect investors and any of the foregoing Persons’
agents or other representatives (including, without limitation, those retained in connection with the transactions contemplated
by this Agreement) (collectively, the “Indemnitees”) from and against any and all actions, causes of
action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith (irrespective
of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable
attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred by any Indemnitee as
a result of, or arising out of, or relating to (a) any misrepresentation or breach of any representation or warranty made by the
Company or any Subsidiary in any of the Transaction Documents, (b) any breach of any covenant, agreement or obligation of the Company
or any Subsidiary contained in any of the Transaction Documents or (c) any cause of action, suit or claim brought or made against
such Indemnitee by a third party (including for these purposes a derivative action brought on behalf of the Company or any Subsidiary)
and arising out of or resulting from (i) the execution, delivery, performance or enforcement of any of the Transaction Documents,
(ii) any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance
of the Securities, or (iii) the status of the Investor or holder of the Securities as an investor in the Company pursuant to the
transactions contemplated by the Transaction Documents. To the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
which is permissible under applicable law. Except as otherwise set forth herein, the mechanics and procedures with respect to the
rights and obligations under this Section 7 shall be the same as those set forth in Section 7 of the Registration Rights Agreement.
Notwithstanding anything to the contrary in this Section 7, the Company shall not be obligated to pay an Indemnitee any sums otherwise
due under this Section 7 if (i) the Company has already paid the Indemnitee such sums for the same Indemnified Liabilities under
Section 7 of the Registration Rights Agreement, or (ii) the Indemnified Liabilities were the result of the gross negligence or
willful misconduct of the Investor.


 


8.             Miscellaneous


 


8.1             
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective
successors and assigns, including, as contemplated below, any assignee or transferee of any of the Securities. The Company shall
not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investor (which may be
granted or withheld in the sole discretion of the Investor), including, without limitation, by way of a Fundamental Transaction
(as defined in the Notes) (unless the Company is in compliance with the applicable provisions governing Fundamental Transactions
set forth in the Notes). The Investor may assign some or all of its rights hereunder in connection with any assignment or transfer
of any of its Securities without the consent of the Company, in which event such assignee or transferee (as the case may be) shall
be deemed to be the Investor hereunder with respect to such assigned rights. Nothing in this Agreement, express or implied, is
intended to confer upon any party, other than the parties hereto or their respective successors and assigns, any rights, remedies,
obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.


 



    	26



    	 



    




 


8.2             
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or
conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the State of New York, County of New York, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees
not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is
improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof by certified mail, return receipt requested, postage prepaid to such party at the
address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.


 


8.3             
Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to
be considered in construing or interpreting this Agreement.


 


8.4             
Notices. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a)
upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business
hours of the recipient; if not, then on the next Trading Day, (c) five (5) Trading Days after having been sent by registered or
certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight
courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to (a) in the case
of the Company, to Virtus Oil and Gas Corp., 1517 San Jacinto, Houston, Texas 77002, Telephone Number: (281) 806-5000, Fax: 281-605-5842,
Attention: M. Rupert Ireland, President, with a copy (which shall not constitute notice) to Brewer & Pritchard, P.C., 3 Riverway,
Suite 1800, Houston, Texas 77056, Telephone Number (713) 209-2911, Fax: (713) 209-2921, Attention: Thomas C. Pritchard or (b) in
the case of the Investor, to Himmil Investments, Ltd., Rodus Building, 4th Floor, Road Town, Tortola, British Virgin
Islands, Telephone Number: (284) 494-8086, Fax: (284) 494-9474, Attention: Arthur C. Price, with a copy (which shall not constitute
notice) to Kelley Drye & Warren LLP, 101 Park Avenue, New York, New York 10178, Telephone Number (212) 808-7540, Fax: (212)
808-7897, Attention: Michael Adelstein.


 


8.5             
Amendments and Waivers. No provision of this Agreement may be amended other than by a written instrument signed by
both parties hereto. No provision of this Agreement may be waived other than in a written instrument signed by the party against
whom enforcement of such waiver is sought. No failure or delay in the exercise of any power, right or privilege hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercises thereof or of any other right, power or privilege.


 



    	27



    	 



    




 


8.6             
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such
provision shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were
so excluded and shall be enforceable in accordance with its terms.


 


8.7             
Entire Agreement. This Agreement and the documents referred to herein constitute the entire agreement among the parties
and no party shall be liable or bound to any other party in any manner by any warranties, representations or covenants except as
specifically set forth herein or therein.


 


8.8             
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument.


 


8.9             
Interpretation. Unless the context of this Agreement clearly requires otherwise, (a) references to the plural include
the singular, the singular the plural, the part the whole, (b) references to any gender include all genders, (c) “including”
has the inclusive meaning frequently identified with the phrase “but not limited to” and (d) references to “hereunder”
or “herein” relate to this Agreement.


 


8.10         
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery
of damages, the Investor and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained
in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation
the defense that a remedy at law would be adequate. The remedies provided in this Agreement and the other Transaction Documents
shall be cumulative and in addition to all other remedies available under this Agreement and the other Transaction Documents, at
law or in equity (including a decree of specific performance and/or other injunctive relief).


 


9.             Certain Defined Terms. In addition to the terms defined elsewhere in this Agreement or the Notes, the following terms
have the meanings set forth in this Section 9:


 


9.1             
“1934 Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder.


 


9.2             
Reserved.


 


9.3             
Reserved.


 


9.4             
“Approved Stock Plan” means any employee benefit plan which has been approved by the board of
directors of the Company prior to or subsequent to the date hereof pursuant to which shares of Common Stock and standard options
to purchase Common Stock may be issued to any employee, officer, consultant or director for services provided to the Company in
their capacity as such.


 



    	28



    	 



    




 


9.5             
“Code” means the U.S. Internal Revenue Code of 1986, as amended.


 


9.6             
“Common Stock Equivalents” means any securities of the Company or the Subsidiaries which would
entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any Convertible Security, Option
or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof
to receive, Common Stock.


 


9.7             
“Convertible Securities” means any capital stock or other security of the Company or any of its
Subsidiaries that is at any time and under any circumstances directly or indirectly convertible into, exercisable or exchangeable
for, or which otherwise entitles the holder thereof to acquire, any capital stock or other security of the Company (including,
without limitation, Common Stock) or any of its Subsidiaries.


 


9.8             
“Effective Date” means the date that the Registration Statement (as defined in the Registration
Rights Agreement) filed pursuant to the Registration Rights Agreement has been declared effective by the Commission.


 


9.9             
“Environmental Laws” means all federal, state, local or foreign laws relating to pollution or
protection of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface
or subsurface strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of
Hazardous Materials into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands or demand letters,
injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations issued, entered, promulgated
or approved thereunder.


 


9.10         
“Excluded Securities” means (A) shares of Common Stock or standard options to purchase Common
Stock to directors, officers, consultants or employees of the Company in their capacity as such pursuant to an Approved Stock Plan,
provided that (1) all such issuances (taking into account the shares of Common Stock issuable upon exercise of such options) after
the date hereof pursuant to this clause (A) do not, in the aggregate, exceed more than 15% of the Common Stock issued and outstanding
immediately prior to the date hereof and (2) the exercise price of any such options is not lowered, none of such options are amended
to increase the number of shares issuable thereunder and none of the terms or conditions of any such options are otherwise materially
changed in any manner that adversely affects the Investor; (B) shares of Common Stock issued upon the conversion or exercise of
Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are
covered by clause (A) above) issued prior to the date hereof, including the Convertible Securities issued in the Investor May 2015
Financing, provided that the conversion price of any such Convertible Securities (other than standard options to purchase Common
Stock issued pursuant to an Approved Stock Plan that are covered by clause (A) above) is not lowered, none of such Convertible
Securities (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by
clause (A) above) are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such
Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are
covered by clause (A) above) are otherwise materially changed in any manner that adversely affects the Investor; (C) the Securities
and shares of Common Stock otherwise issued pursuant to obligations set forth in the Notes or the Registration Rights Agreement,
(D) shares of Common Stock or Convertible Securities issued or issuable in connection with strategic alliances, acquisitions, mergers,
and strategic partnerships, provided, that (1) the primary purpose of such issuance is not to raise capital, (2) the purchasers
or acquirers of the securities in such issuance does not include any affiliate of the Company or any of its Subsidiaries and solely
consists of either (x) the actual participants in such strategic alliance or strategic partnership, (y) the actual owners of such
assets or securities acquired in such acquisition or merger or (z) the stockholders, partners or members of the foregoing Persons,
and (3) the number or amount of securities issued to such Person by the Company shall not be disproportionate to such Person’s
actual participation in such strategic alliance or strategic partnership or ownership of such assets or securities to be acquired
by the Company, as applicable, (E) shares of Common Stock issued or issuable by reason of a dividend, stock split, or other distribution,
(F) the issuance of up to $500,000 of Common Stock to be sold in private placement transactions during the 12-month period from
the date hereof to Fieldstone Partners (or its affiliates) and/or Mablewood Investments (or its affiliates); provided that (1)
the terms of issuance of such Common Stock (or any securities convertible, exercisable or exchangeable into Common Stock) do not
contemplate the issuance of additional shares of Common Stock including by way of any reset, make-whole or similar provisions and
(2) the terms of such issuance do not provide for the right to include the registration of such shares of Common Stock on any registration
statement filed pursuant to the Registration Rights Agreement, and (G) shares of Common Stock to be issued pursuant to the employment
agreement dated May 13, 2014 by and between the Company and Rupert Ireland and the consulting agreement dated June 1, 2014 by and
between the Company and Brett A. Murray & Associates dated prior to the date hereof, provided that (1) such agreements are
not amended to increase the number of shares issuable thereunder and the terms of issuance of such Common Stock (or any securities
convertible, exercisable or exchangeable into Common Stock) do not contemplate the issuance of additional shares of Common Stock
including by way of any reset, make-whole or similar provisions and (2) such agreements do not provide for the right to include
the registration of such shares of Common Stock on any registration statement filed pursuant to the Registration Rights Agreement.


 



    	29



    	 



    




 


9.11         
“Hazardous Materials” means chemicals, pollutants, contaminants, or toxic or hazardous substances
or wastes.


 


9.12         
“Indebtedness” means (A) any liabilities for borrowed money or amounts owed in excess of $100,000
(other than trade accounts payable incurred in the ordinary course of business), (B) all guaranties, endorsements and other contingent
obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company’s consolidated
balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business, and (C) the present value of any lease payments in excess of $100,000 due under
leases required to be capitalized in accordance with GAAP.


 


9.13         
“Liens” means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive
right or other restriction.


 


9.14         
“Material Adverse Effect” means (i) a material adverse effect on the legality, validity or enforceability
of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition
(financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s
ability to perform in any material respect on a timely basis its obligations under any Transaction Document, except that any of
the following, either alone or in combination, shall not be deemed a Material Adverse Effect: (i) effects caused by changes or
circumstances affecting general market conditions in the U.S. economy or which are generally applicable to the industry in which
the Company operates, provided that such effects are not borne disproportionately by the Company; (ii) effects caused by earthquakes,
hostilities, acts of war, sabotage or terrorism or military actions or any escalation or material worsening of any such hostilities,
acts of war, sabotage or terrorism or military actions existing as of the date hereof; (iii) effects resulting from or relating
to the announcement or disclosure of the sale of the Securities or other transactions contemplated by this Agreement or the Transaction
Documents; (iv) effects caused by any event, occurrence or condition resulting from or relating to the taking of any action as
required in accordance with this Agreement or the Transaction Documents; or (v) effects to the market price of the Company’s
common stock or any other oil and gas company common stock on any Trading Market as a result of market, political, economic or
other conditions.


 


9.15         
“Permitted Indebtedness” means (i) Indebtedness evidenced by this Note and the Other Notes, (ii)
Indebtedness outstanding as of the quarter ended May 30, 2015 (including the Investor May 2015 Financing), (iii) Indebtedness secured
by Permitted Liens in an aggregate amount not to exceed $250,000, (iv) Indebtedness incurred by the Company that is made expressly
subordinate in right of payment to the Notes and Other Notes, (v) obligations in respect of performance, bid, appeal and surety
bonds and completion guarantees and similar obligations provided in the ordinary course of business, (vi) Indebtedness arising
from the honoring by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds
in the ordinary course of business, (vii) Indebtedness consisting of the financing of insurance premiums or take-or-pay obligations
contained in supply arrangements in each case, incurred in the ordinary course of business, (viii) capital leases entered into
in the ordinary course of business, (ix) Indebtedness related to trade account payables incurred in the ordinary course of the
Company’s or its Subsidiaries’ business or credit card debt associated with the payment of the foregoing, (x) Trade
Indebtedness, (xi) hedging activities relating to the Company’s oil and gas operations, and (xii) any item described in the
definition of Indebtedness that was not Indebtedness on the date of the Securities Purchase Agreement that becomes Indebtedness
after the date of the Securities Purchase Agreement as a result of a change in accounting treatment or accounting treatment as
a result of the Transaction Documents.


 


9.16         
“Person” means any individual, partnership, firm, corporation, limited liability company, association,
trust, unincorporated organization or other entity, as well as any syndicate or group that would be deemed to be a person under
Section 13(d)(3) of the 1934 Act. For all purposes of this Agreement, violations of the restrictions set forth in Section 4.13
by any Subsidiary or affiliate of the Company, or any officer, employee, director, agent or other representative of the Company
or any of its Subsidiaries or affiliates shall be deemed a direct breach of Section 4.13 by the Company.


 



    	30



    	 



    




 


9.17         
“Qualified Real Property” means real property reasonably prospective for oil and gas resources.


 


9.18         
“Rule 144” means Rule 144 promulgated under the 1933 Act or a successor rule thereto.


 


9.19         
“Short Sales” means “short sales” as defined in Rule 200 promulgated under Regulation
SHO under the 1934 Act.


 


9.20         
“Subsidiary” means any corporation or other entity of which at least a majority of the securities
or other ownership interest having ordinary voting power for the election of directors or other persons performing similar functions
are at the time owned directly or indirectly by the Company and/or any of its other Subsidiaries.


 


9.21         
“Trade Indebtedness” means Indebtedness incurred by the Company in the normal course of drilling,
operating, producing and maintaining Qualified Real Property in connection with (i) vendor contracts, (ii) partnership, joint venture,
farm-in, farm-out, joint operating and similar arrangements and agreements, and (iii) related contractual obligations.


 


9.22         
“Trading Day” means any day on which the Common Stock is traded on the Trading Market, provided
that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on the Trading
Market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on the
Trading Market (or if the Trading Market does not designate in advance the closing time of trading on the Trading Market, then
during the hour ending at 4:00:00 p.m., New York City time) unless such day is otherwise designated as a Trading Day in writing
by the Investor.


 


9.23         
“Trading Market” means any of the following markets or exchanges on which the Common Stock is
listed or quoted for trading on the date in question: the OTC Bulletin Board, The NASDAQ Global Market, The NASDAQ Global Select
Market, The NASDAQ Capital Market, the New York Stock Exchange, NYSE Arca, the NYSE MKT, or the OTCQX Marketplace or the OTCQB
Marketplace operated by OTC Markets Group Inc. (or any successor to any of the foregoing).


 


9.24         
“Variable Rate Transaction” means a transaction in which the Company or any Subsidiary (i) issues
or sells any Convertible Securities either (A) at a conversion, exercise or exchange rate or other price that is based upon and/or
varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such Convertible
Securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial
issuance of such Convertible Securities or upon the occurrence of specified or contingent events directly or indirectly related
to the business of the Company or the market for the Common Stock, including, without limitation, pursuant to any “weighted
average” or “full-ratchet” anti-dilution provision, or (ii) enters into any agreement (including, without limitation,
an equity line of credit or an “at-the-market” offering) whereby the Company or any Subsidiary may sell securities
at a future determined price.


 


[SIGNATURES ON THE
FOLLOWING PAGE]


 



    	31



    	 



    




 


IN WITNESS WHEREOF,
the parties have caused this Agreement to be duly executed and delivered as of the date provided above.


 





	 	THE COMPANY
	 	 
	 	VIRTUS OIL AND GAS CORP.
	 	 
	 	 
	 	By:                                         
	 	       Name: M. Rupert Ireland
	 	       Title: President and Chief Executive Officer




 





  






    	32



    	 



    

 


IN WITNESS WHEREOF,
the parties have caused this Agreement to be duly executed and delivered as of the date provided above.


 





	 	THE INVESTOR:
	 	 
	 	 
	 	HIMMIL INVESTMENTS, LTD. 
	 	 
	 	By:                                         
	 	       Name: Arthur C. Price
	 	       Title: Director







 






    	33



    	 



    

 


Schedule I


 


	(1)	(2)	(3)	(4)	(5)
	 	 	 	 	 
	
        Investor
	
        Address
        and Facsimile Number
	
        Original
        Principal Amount of Initial Notes
	
        Original
        Issuance Discount
	
        Purchase
        Price

	 	 	 	 	 
	Himmill Investments, Ltd.	
        Rodus Building, 4 floor

        Road Town, Tortola

        British Virgin Islands

        Tel: (284) 494-8086

        Fax: (284) 494-9474

        Attention: Arthur C. Price

         

        with a copy (which shall not constitute notice) to

         

        Kelley Drye & Warren LLP

        101 Park Avenue

        New York, New York 10178

        Tel: (212) 808-7540

        Fax: (212) 808-7897

        Attention: Michael Adelstein
	$600,000	$25,000	$375,000


 


 



    	34